Local authorities locked down the area surrounding the factory on Wednesday, but not before reports surfaced of a lack of proper medical care at the plant.
On Sunday, Apple said it had temporarily reduced iPhone 14 production due to Covid-19 restrictions at its assembly plant in China.
Apple said it would ship fewer units and customers would have to wait longer.
“The facility is currently operating at a significantly reduced capacity,” Apple’s statement said.
It means that iPhone 14 shipments could be affected before the holiday shopping season.
The move will have a significant impact on Apple’s quarterly sales and make it harder for consumers to get their hands on Apple’s high-end models.
“We continue to see strong demand for the iPhone 14 Pro and iPhone 14 Pro Max models,” Apple’s press release said.
“However, we now expect lower iPhone 14 Pro and iPhone 14 Pro Max shipments than we previously anticipated, and customers will experience longer wait times to receive their new products,” he added.
This comes as an iPhone 14 Pro assembly plant in Zhengzhou, a mega-factory owned by Taiwanese company Foxconn, which is a major supplier to Apple, is on lockdown due to the spread of Covid.
Apple said the Zhengzhou plant is its primary facility for manufacturing the Pro models, adding that it was “working closely with our supplier to return to normal production levels while ensuring the health and safety of all workers.” .
China has been hit hard by Covid-19 restrictions, and Zhengzhou employs thousands of workers making iPhones and other high-end electronics.
In early October, plant supervisors suddenly announced that 3,000 workers had been quarantined after someone tested positive for COVID-19 at the factory.
Meanwhile, Foxconn has said it faces a “protracted battle” against infections and has imposed a closed-loop bubble around its sprawling campus in Zhengzhou, central China.
Local authorities locked down the area surrounding the factory on Wednesday, but not before reports emerged of employees fleeing on foot and a lack of proper medical care at the plant.
China remains committed to a zero-Covid strategy, persisting with rapid lockdowns, mass testing and lengthy quarantines in a bid to stamp out emerging outbreaks.